Revelation Biosciences Inc.

REVB | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.96

-$0.02 (-1.67%)

At close: Sep 22, 2026, 3:59 PM ET

$0.93

-$0.03 (-3.10%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $3.82M

Enterprise Value $-6.93M

Beta -0.17

Average Volume 47.61K

Shares Outstanding (Diluted) 3.83M

Shares Change YoY 377.08%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US76135L8046

Price Performance

Price Change 1M -10.9%

Price Change 3M -6.7%

Price Change 6M -16.9%

Price Change YTD -69.8%

Price Change 1Y -83.9%

Price Change 3Y -100.0%

Price Change 5Y -100.0%

1M CAGR (ann.) -14.4%

1Y CAGR (ann.) -84.3%

5Y CAGR (ann.) -93.2%

All-Time CAGR -89.9%

Valuation

PE Ratio -0.14

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS 1.70

PB Ratio 0.38

P/FCF Ratio -0.30

P/Adj. FCF Ratio -0.26

P/OCF Ratio -0.40

EV/Sales N/A

EV/EBIT 0.63

EV/EBITDA 0.64

EV/FCF 0.54

Earnings Yield -714.3%

FCF Yield -333.5%

Adj. FCF Yield -378.4%

Financial Health

Net Cash $10.74M

Total Debt $739.92K

Cash & Short-Term Investments $11.48M

Total Assets $12.5M

Current Ratio 6.21

Quick Ratio 6.21

Debt / Equity Ratio 0.07

Debt / EBITDA -0.07

Debt / FCF -0.06

OCF / Debt -16.95

Interest Coverage 0.00

Altman Z-Score -7.25

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -13.5%

Returns

Return on Assets -86.0%

Return on Equity -100.2%

Return on Invested Capital -104.3%

Return on Capital Employed -106.1%

Return on Tangible Assets -86.0%

Historical Growth (CAGR)

Revenue CAGR 3Y -87.3%

Revenue CAGR 5Y 20.9%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 137.3%

EPS CAGR 5Y 96.2%

EPS CAGR 10Y N/A

FCF CAGR 3Y -13.9%

FCF CAGR 5Y -8.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 49.7%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.88

EPS Growth Est (next Q) -87.6%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-12.54M

Free Cash Flow $-12.73M

Adj. Free Cash Flow $-14.44M

FCF Per Share -$2.47

OCF Per Share -$2.44

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-19.82K

Operating Income $-11.27M

EBITDA $-10.9M

Net Income $-10.75M

EPS (Diluted) -$7

Revenue / Employee N/A

Profit / Employee $-1.34M

Employees 8